Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-P15-041 PET/CT for Bone Tumors
NCT06455722Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- PET/CT (Positron Emission Tomography/Computed Tomography)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [68Ga]Ga-P15-041 in Bone tumor (BT) and bone metastases, sponsored by The First Hospital of Fujian Medical University. Primary endpoints: detection capability at 6 months and tumor uptake at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
[68Ga]Ga-P15-041
03
Conditions
Bone tumor (BT)bone metastases
Beyond the preview
Go deeper on NCT06455722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06455722.